Ting Zhou

3.4k total citations
117 papers, 2.0k citations indexed

About

Ting Zhou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ting Zhou has authored 117 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 40 papers in Pulmonary and Respiratory Medicine and 30 papers in Molecular Biology. Recurrent topics in Ting Zhou's work include Lung Cancer Treatments and Mutations (30 papers), Lung Cancer Research Studies (30 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Ting Zhou is often cited by papers focused on Lung Cancer Treatments and Mutations (30 papers), Lung Cancer Research Studies (30 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Ting Zhou collaborates with scholars based in China, United States and Canada. Ting Zhou's co-authors include Yan Huang, Yunpeng Yang, Yuanyuan Zhao, Hongyun Zhao, Wenfeng Fang, Yuxiang Ma, Shaodong Hong, Xue Hou, Jianhua Zhan and Zhihuang Hu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ting Zhou

108 papers receiving 2.0k citations

Peers

Ting Zhou
Sally Temraz Lebanon
Lanwei Guo China
In‐Jae Oh South Korea
Anne M. Noonan United States
Christos Damaskos Greece
Claire Jones Canada
Theodoros Karantanos United States
Fang Wu China
Sally Temraz Lebanon
Ting Zhou
Citations per year, relative to Ting Zhou Ting Zhou (= 1×) peers Sally Temraz

Countries citing papers authored by Ting Zhou

Since Specialization
Citations

This map shows the geographic impact of Ting Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Zhou more than expected).

Fields of papers citing papers by Ting Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Zhou. The network helps show where Ting Zhou may publish in the future.

Co-authorship network of co-authors of Ting Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Ting Zhou. A scholar is included among the top collaborators of Ting Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting Zhou. Ting Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xing, et al.. (2025). Efficacy of pulmonary rehabilitation on health-related quality of life in patients with interstitial lung disease as assessed by SF-36: a systematic review and meta-analysis. European Journal of Physical and Rehabilitation Medicine. 61(2). 313–334. 1 indexed citations
2.
Zhang, Jun, Ting Zhou, Kejun Dong, et al.. (2025). IL-6/KIAA1429 promotes ferroptosis resistance in endometrial cancer through m6A modification of DDIT3. Cellular Signalling. 134. 111906–111906.
3.
Zhao, Zhen, Yujie Zhou, Peng Lv, et al.. (2024). NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization. Cancer Letters. 597. 217059–217059. 19 indexed citations
4.
Ma, Wenjuan, Ting Zhou, Mengmeng Song, et al.. (2024). Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype. Journal of Translational Medicine. 22(1). 189–189. 1 indexed citations
5.
Zhang, Qi, Ting Zhou, Yingying Peng, et al.. (2024). Dual-Multivalent Aptamer-Based Drug Delivery Platform for Targeted SRC Silencing to Enhance Doxorubicin Sensitivity in Endometrial Cancer. International Journal of Biological Sciences. 20(15). 5812–5830. 4 indexed citations
6.
Cui, Yunying, et al.. (2024). Pheochromocytoma in von Hippel‐Lindau Disease: Clinical Features and Comparison With Sporadic Pheochromocytoma. Clinical Endocrinology. 102(3). 355–361.
7.
Wang, Shuai, et al.. (2024). Causal Effects of Gut Microbiota and Metabolites on Chronic Obstructive Pulmonary Disease: A Bidirectional Two Sample Mendelian Randomization Study. International Journal of COPD. Volume 19. 2153–2167. 1 indexed citations
8.
Luo, Fan, Jiaxin Cao, Xue Bai, et al.. (2024). HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype. Journal for ImmunoTherapy of Cancer. 12(6). e008146–e008146. 3 indexed citations
9.
Huang, Yan, Yunpeng Yang, Yuanyuan Zhao, et al.. (2024). QL1706 (anti-PD-1 IgG4/CTLA-4 antibody) plus chemotherapy with or without bevacizumab in advanced non-small cell lung cancer: a multi-cohort, phase II study. Signal Transduction and Targeted Therapy. 9(1). 23–23. 10 indexed citations
10.
Fang, Wenfeng, Yunpeng Yang, Yan Huang, et al.. (2023). 74P A single-center, phase II study of surufatinib combined with toripalimab, pemetrexed(A), and platinum (P) in patients with advanced non-squamous non-small cell lung cancer (nsq-NSCLC). Immuno-Oncology Technology. 20. 100546–100546. 1 indexed citations
11.
Luo, Songyuan, Wei Li, Jitao Liu, et al.. (2023). Association between the non-HDL-cholesterol to HDL- cholesterol ratio and abdominal aortic aneurysm from a Chinese screening program. Lipids in Health and Disease. 22(1). 187–187. 24 indexed citations
12.
Chen, Xiaoning, Tao Zhou, Ting Zhou, et al.. (2023). Effects of proton pump inhibitor on gastroesophageal varices in patients with cirrhosis: A randomized controlled trial from China. SHILAP Revista de lepidopterología. 2(1). 1–8.
13.
Luo, Fan, Han Li, Wenjuan Ma, et al.. (2023). The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation. Cellular and Molecular Immunology. 21(1). 60–79. 37 indexed citations
14.
Cao, Jiaxin, Qun Chen, Xue Bai, et al.. (2023). Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors. Annals of Medicine. 55(2). 2280002–2280002. 16 indexed citations
15.
Zhou, Ting, et al.. (2021). Curcumin alleviates imiquimod-induced psoriasis in progranulin-knockout mice. European Journal of Pharmacology. 909. 174431–174431. 19 indexed citations
16.
Zhang, Zhonghan, Yang Zhang, Fan Luo, et al.. (2020). Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first‐line treatment for advanced EGFR‐mutant non‐small cell lung cancer. SHILAP Revista de lepidopterología. 10(2). e33–e33. 15 indexed citations
17.
Lu, Jianfei, et al.. (2020). Identification and characterization of a tumor necrosis factor receptor like protein encoded by Cyprinid Herpesvirus 2. Developmental & Comparative Immunology. 116. 103930–103930. 7 indexed citations
18.
Hua, Yingpeng, et al.. (2019). Bioinformatics analysis and response to nitrate-cadmium stress of NRT1.5 and NRT1.8 family genes in Brassica napus. ACTA AGRONOMICA SINICA. 45(3). 365–380. 2 indexed citations
19.
Ma, Yuxiang, Yunpeng Yang, Yan Huang, et al.. (2014). An investigation of symptom burden and quality of life in Chinese chemo-naïve advanced lung cancer patients by using the Instrument-Cloud QOL System. Lung Cancer. 84(3). 301–306. 10 indexed citations
20.
Li, Wang, et al.. (2011). Association between PR/AR gene polymorphisms and susceptibility to epithelial ovarian cancer.. Journal of Shandong University. 49(9). 144–148. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sally Temraz Breakdown of academic impact, for papers by Lanwei Guo Breakdown of academic impact, for papers by In‐Jae Oh Breakdown of academic impact, for papers by Anne M. Noonan Breakdown of academic impact, for papers by Christos Damaskos Breakdown of academic impact, for papers by Claire Jones Breakdown of academic impact, for papers by Theodoros Karantanos Breakdown of academic impact, for papers by Fang Wu
Rankless by CCL
2026